Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category
    Loading...
  • Global United States
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibilityarrow down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
Back

Post navigation

Previous
Next

TAZVERIK® Vermont Pharmaceutical Price Disclosure Long Form

TAZVERIK® Vermont Pharmaceutical Price Disclosure Long Form

- 16 January 2024 - 0 mins read

Post navigation

Previous
Next

Related Documents

  • Download Long Form   Download  (2 MB)

Related Reports and Accounts

IQIRVO® Vermont Pharmaceutical Price Disclosure Long Form
14 June 2024 0 mins read

IQIRVO® Vermont Pharmaceutical Price Disclosure Long Form
IQIRVO® Vermont Pharmaceutical Price Disclosure Short Form
14 June 2024 0 mins read

IQIRVO® Vermont Pharmaceutical Price Disclosure Short Form
Connecticut Pharmaceutical Price Disclosure
07 March 2024 0 mins read

Connecticut Pharmaceutical Price Disclosure
TAZVERIK® Vermont Pharmaceutical Price Disclosure Short Form
01 November 2023 0 mins read

TAZVERIK® Vermont Pharmaceutical Price Disclosure Short Form
Colorado Pharmaceutical Price Disclosure
26 September 2023 0 mins read

Colorado Pharmaceutical Price Disclosure
BYLVAY® Vermont Pharmaceutical Price Disclosure Short Form
26 September 2023 0 mins read

BYLVAY® Vermont Pharmaceutical Price Disclosure Short Form
SOHONOS™ Vermont Pharmaceutical Price Disclosure Short Form
26 September 2023 0 mins read

SOHONOS™ Vermont Pharmaceutical Price Disclosure Short Form
BYLVAY® Vermont Pharmaceutical Price Disclosure Long Form
26 September 2023 0 mins read

BYLVAY® Vermont Pharmaceutical Price Disclosure Long Form
SOHONOS™ Vermont Pharmaceutical Price Disclosure Long Form
26 September 2023 0 mins read

SOHONOS™ Vermont Pharmaceutical Price Disclosure Long Form

IPN price

€98.85

 €-0.45 (-0.45%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft
Latest_Ipsen logo
LinkedIn Facebook Instagram Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2025

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue